Background: Infants of extremely low gestational age are at high risk for lung disease continuing through childhood. Pathogenic mechanisms are not fully defined and there are currently no clinically useful biomarkers to assess risk.
ANTENATAL CORTICOSTEROID PRESCRIBING PRACTICES
Background: Administration of antenatal corticosteroids is a key pillar in the care of infants born prematurely. Unfortunately, accurate diagnosis of women who progress to preterm delivery continues to be poor, and thus the appropriate selection of patients who would benefit from antenatal corticosteroids is difficult.
Aim: To describe antenatal corticosteroid prescribing practices at a single tertiary hospital over a five-year period.
Methods: Antenatal and birth details of all women who delivered between January 2011 to December 2015 were collected from an electronic obstetric database. The rate of antenatal corticosteroid prescription for each group of woman was recorded and analysed using chi-squared tests.
Results: Sixty-five percent of women who delivered prior to 34 weeks gestation received antenatal corticosteroids. Of these women, 63% received antenatal corticosteroids appropriately and delivered within 7 days. Women most likely to receive antenatal corticosteroids appropriately were primiparous (RR 1.25 CI 1.08-1.45), or those diagnosed with pre-eclampsia (RR 1.34, CI 1.10-1.63), preterm premature rupture of membranes (RR 1.33, CI 1.15-1.54) or threatened preterm labour (1.42, CI 1.22-1.65). Twenty-two percent of women who received antenatal corticosteroids prior to 34 weeks subsequently delivered late preterm (34 +0 -36 +6 weeks) and 17% delivered at term. During the study period there was no significant change in steroid prescribing patterns (P > 0.38).
Conclusions: A significant number of women and babies are exposed to antenatal corticosteroids that deliver after seven days of administration or greater than 34 weeks gestation. The lifelong impact of this practice is not known and requires further research. foetuses are recognised to be at increased risk of stillbirth, neonatal death and serious neonatal morbidity. However, SGA is frequently undetected as no routine estimate of fetal weight (EFW) occurs in the third trimester in low risk women. The aim of this study was to assess if EFW z-score or EFW z-score change/week was associated with adverse perinatal outcomes. Methods: A blinded, prospective, panel study was conducted at Mater Mothers' Hospital in low risk women with singleton pregnancies who were planning a vaginal delivery. Women underwent ultrasound fortnightly from 36 weeks to calculate EFW. The z-score and z-score change/week for EFW was calculated and compared between mode of birth and those with and without adverse neonatal outcomes (ANO; acidosis, Apgar <7 at 5 minutes and/or neonatal unit admission).
FETAL WEIGHT Z-SCORES IN LATE PREGNANCY ARE LOWER AND DECLINE IN THOSE WITH ADVERSE PERINATAL OUTCOMES
Results: 402 women met inclusion criteria and were included in the final analysis. EFW z-scores were lower for babies born with acidosis, neonatal unit admission or the ANO (P < 0.01, P < 0.05 and P < 0.05, respectively). For EFW z-score change/-week, babies with ANO demonstrated a decrease whilst those without ANO experienced an increase (−0.04 vs. 0.02, P = 0.02, respectively).
Conclusions: From 36 weeks, EFW z-scores are lower and decline in foetuses who experience adverse perinatal outcomes.
